Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Ramiprilat

EU orphan designation number: EU/3/13/1117   
Active ingredient: Ramiprilat
Indication: Treatment of Stargardt’s disease
Sponsor: Iris Pharma
Les Nertières, allée Hector Pintus, F-06610 La Gaude, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/03/2013 Orphan designation EMA/OD/175/12 (2013)1611 of 12/03/2013